A:exemestane

2 trials

Sponsors

Department of Oncology, East District of Suzhou Municipal Hospital, Department of Breast Medical Oncology, Beijing Cancer Hospital

Conditions

breast cancer

Phase 4

Phase II exemestane versus paclitaxel as first-line treatment of patients with metastatic hormone receptor positive breast cancer

RecruitingChiCTR-IPR-17010455

Department of Breast Medical Oncology, Beijing Cancer Hospitalbreast cancer

Start: 2017-01-20Updated: 2017-04-18

Clinical study for exemestane with metronomic capecitabine in the second-line treatment of metastatic breast cancer

Active, not recruitingChiCTR1800018415

Department of Oncology, East District of Suzhou Municipal Hospitalbreast cancer

Start: 2018-10-20Updated: 2018-09-24